Mapping the landscape of managed entry agreements: a systematic review of global frameworks, system-level components, and implementation challenges
BackgroundManaged Entry Agreements (MEAs) are pivotal for enabling access to innovative pharmaceuticals while mitigating financial risk and addressing evidence uncertainty. Despite conceptual acceptance, the essential requirements for their design and implementation are poorly documented, posing a c...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2026-04-01
|
| Reeks: | Frontiers in Pharmacology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1803870/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
